Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Alx Oncology Holdings (ALXO) Return on Assets (2020 - 2023)

Alx Oncology Holdings' Return on Assets history spans 4 years, with the latest figure at 0.63% for Q3 2023.

  • For Q3 2023, Return on Assets fell 42.0% year-over-year to 0.63%; the TTM value through Sep 2023 reached 0.63%, down 42.0%, while the annual FY2022 figure was 0.04%, 4.0% up from the prior year.
  • Return on Assets for Q3 2023 was 0.63% at Alx Oncology Holdings, down from 0.5% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.08% in Q4 2021 and bottomed at 0.63% in Q3 2023.
  • The 4-year median for Return on Assets is 0.16% (2021), against an average of 0.24%.
  • The largest annual shift saw Return on Assets rose 3bps in 2021 before it tumbled -42bps in 2023.
  • A 4-year view of Return on Assets shows it stood at 0.1% in 2020, then increased by 25bps to 0.08% in 2021, then crashed by -404bps to 0.4% in 2022, then plummeted by -59bps to 0.63% in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Return on Assets are 0.63% (Q3 2023), 0.5% (Q2 2023), and 0.44% (Q1 2023).